A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
Clinical trial NCT06364696 · TERMINATED
Trial details
- NCT number
- NCT06364696
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2026-06-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.